How much funding has Abbelight raised?

Abbelight has raised $100.0M in total funding, most recently a Series B round.

Who are Abbelight's investors?

Abbelight's investors include AVANT BIO, Odyssee Venture, European Innovation Council Fund, Pleiade Venture.

Where is Abbelight headquartered?

Abbelight is headquartered in Cachan, France.

What industry is Abbelight in?

Abbelight operates in Biotech, Deep Tech.

Abbelight

From Microscopy to Nanoscopy

Cachan, France · Founded 2016 · $100.0M raised

Biotech

Deep Tech

Headquarters: Cachan
Founded: 2016
Business Model: B2B
Website: abbelight.com

Total Funding: $100.0M
Last Round: $100.0M Series BJan 2026
Rounds: 1

About

Abbelight is a French bioimaging company founded in 2016 that develops advanced fluorescence microscopy and super-resolution nanoscopy platforms for researchers, biotech labs, and medical facilities worldwide. Its SAFe platform family integrates single-molecule localization microscopy (SMLM) hardware, proprietary consumables for sample preparation, and end-to-end bioinformatics software into a single workflow solution. With over 100 systems installed across more than 200 users and 90+ scientific publications leveraging its products, Abbelight serves applications spanning neuroscience, cell biology, microbiology, genomics, and extracellular vesicle research.

Summary

Abbelight is a Biotech company based in Cachan, France, founded in 2016. It has raised $100.0M in total across 1 round, most recently a $100.0M Series B round in Jan 2026. Investors include AVANT BIO, Odyssee Venture and European Innovation Council Fund.